Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs

Table 5

Difference in baseline characteristics between different drops of HbA1c.

	High degree (≥0.6%)	Mid degree (0.3-0.5%)	Low degree (≤0.2%)
Age (years)				0.108
Duration (years)				0.641
Body weight (kg)				0.362
BMI (kg/m^2)				0.331
Waist-to-hip ratio				0.025
eGFR (mL/min^-1/1.73 m^2)				0.086
HbA1c (%)				0.029
Insulin dose (IU/d)				0.606
HOMA-CR				0.723
HOMA-beta				0.584

Data were shown as or median (first quartile, third quartile). BMI: body mass index; eGFR: estimated glomerular filtration rate; HbA1c: glycosylated hemoglobin; HOMA-CR: homeostasis model assessment of C-peptide secretion; HOMA-beta: homeostasis model assessment for pancreatic beta-cell.